| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.8 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.0058 | 0.8 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.0065 | 0.8 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.8 |